These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2540362

  • 21. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS, Fung HB.
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
    Troke PF, Andrews RJ, Brammer KW, Marriott MS, Richardson K.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):815-8. PubMed ID: 3002246
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of fluconazole in a patient with documented malabsorption of ketoconazole.
    Drew RH, Perfect JR, Gallis HA.
    Clin Pharm; 1988 Aug; 7(8):622-3. PubMed ID: 2844468
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Aug; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 30. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS, Fessel WJ, Kaufman CA, Merrill KW, Ward DJ, Moskovitz BL, Thomas C, Oleka N, Guarnieri JA, Lee J, Brenner-Gati L, Klausner M.
    AIDS Res Hum Retroviruses; 1999 Nov 01; 15(16):1413-7. PubMed ID: 10555103
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec 01; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Fluconazole in the treatment of deep-seated candidiasis in surgical patients].
    Viviani MA, Tortorano AM, Pagano A, Sallusti M, Basadonna G, Rizzitelli E, Raiteri M, Viglino G.
    G Ital Chemioter; 1988 Dec 01; 35(1-3):57-60. PubMed ID: 2855729
    [No Abstract] [Full Text] [Related]

  • 37. In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
    Tanio T, Ichise K, Nakajima T, Okuda T.
    Antimicrob Agents Chemother; 1990 Jun 01; 34(6):980-4. PubMed ID: 2203310
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of ravuconazole, a new triazole antifungal, in a rat intraabdominal abscess model.
    Mikamo H, Yin XH, Hayasaki Y, Satoh M, Tamaya T.
    Chemotherapy; 2001 Jun 01; 47(5):377-80. PubMed ID: 11561141
    [Abstract] [Full Text] [Related]

  • 40. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.
    Grant SM, Clissold SP.
    Drugs; 1990 Jun 01; 39(6):877-916. PubMed ID: 2196167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.